0.10
—
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Asep Medical Holdings
Its shares trade on Canadian Securities Exchange under the ticker ASEP.CN. It has been listed since 22 November 2021. In the fiscal year to 31 December 2025, it reported revenue of C$336,773 and a net loss of C$4.9m. At that date it held total assets of C$8.7m and shareholders' equity of C$2.3m.
ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-11-22. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The company provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The firm also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The firm also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. The company has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 22 Nov 2021
- Website
- asepmedical.com ↗
Leadership
Pay as last reported
- Dr. Robert HancockChief Executive Officer, Director, since 2021C$45,000
- Ms. Jacqueline TuckerChief Financial OfficerC$22,500
- Mr. Timothy MurphyChief Operating Officer, Company Secretary, Director, since 2021C$60,000
- Dr. Evan HaneyChief Science OfficerC$77,242
- Dr. Fadia SaadChief Business Development OfficerC$180,000
- Dr. Richard HeinzlIndependent DirectorC$18,000
- Mr. Derrold NorgaardIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Asep Medical Holdings Inc. provides medical devices with anti-microbial coating through SafeCoat Medical Inc.
- Sepset Biosciences Inc. offers diagnostic kits for predicting severe sepsis and organ failure.
- ABT Innovations Inc. delivers peptide technology for diagnostic and therapeutic applications.
Weaknesses
- The company consolidates three development-stage companies requiring significant investment.
- Vancouver, British Columbia headquarters location may limit access to global markets.
- The IPO on 22 November 2021 indicates recent market entry with limited track record.
Opportunities
- Expanding sepsis diagnostic market in North America presents growth potential.
- Increasing demand for anti-microbial medical devices globally offers new markets.
- Collaborations with healthcare providers in the United States could drive adoption.
Threats
- Competition from established medical device companies in the United States.
- Regulatory challenges in the Health Care sector may delay product approvals.
- Economic downturns could reduce healthcare spending on new diagnostics.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.